Theophylline Metabolism after Cardiac Surgery

The effect and metabolism of theophylline administration after cardiac surgery has never been reported. Two series of 2‐hour intravenous aminophylline administrations (3 mg/kg/h) were conducted in 10 adult patients on the operative day (acute phase) and on the 4th or 5th postoperative day (recovery phase). Both blood and urine samples were collected for 24 hours after dosing. Heart rate increased in both phases, but the cardiac index increased with the decrease of diastolic blood pressure only in the acute phase (p < 0.05). Plasma concentration levels of theophylline tended to be slightly higher in the acute phase, and renal clearance increased in the recovery phase (p < 0.05). The urinary ratio of 3‐methylxanthine to theophylline was significantly higher in the acute phase (p < 0.05). This suggests that cytochrome P4501A2 is partially activated rather than depressed and that N‐demethylation is promoted more than hydroxylation immediately after surgery.

[1]  J. Lipsky,et al.  Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice. , 1998, Mayo Clinic proceedings.

[2]  L. Williamson.  Postoperative care--2. , 1998, Nursing times.

[3]  L. Kaminsky,et al.  Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. , 1995, Biochemical pharmacology.

[4]  M. Huic,et al.  Pharmacokinetic Changes in Patients With Oedema , 1995, Clinical pharmacokinetics.

[5]  U. Tröger,et al.  Influence of Endogenous and Exogenous Effectors on the Pharmacokinetics of Theophylline , 1995, Clinical pharmacokinetics.

[6]  M. Sarkar,et al.  Theophylline N-demethylations as probes for P4501A1 and P4501A2. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[7]  R. Pauwels,et al.  Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.

[8]  Daniel W. Jones,et al.  Theophylline Disposition in Korean Patients with Congestive Heart Failure , 1994, The Annals of pharmacotherapy.

[9]  U. Fuhr,et al.  Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. , 1992, Biochemical pharmacology.

[10]  J. Miners,et al.  Characterisation of theophylline metabolism in human liver microsomes. , 1987, British journal of clinical pharmacology.

[11]  R. Upton,et al.  Pharmacokinetic Drug Interactions with Theophylline , 1984, Clinical pharmacokinetics.

[12]  L Hendeles,et al.  Theophylline A “State of the Art” Review , 1983, Pharmacotherapy.

[13]  S. Riegelman,et al.  An automated HPLC assay for simultaneous quantitation of methylated xanthines and uric acids in urine. , 1982, Journal of chromatographic science.

[14]  R. Ogilvie.  Clinical Pharmacokinetics of Theophylline , 1978, Clinical pharmacokinetics.

[15]  W. Jusko,et al.  Pharmacokinetics of theophylline in hepatic disease. , 1978, Chest.

[16]  B. A. Miller,et al.  Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure. , 1977, American journal of hospital pharmacy.

[17]  R. Ogilvie,et al.  Theophylline kinetics in acute pulmonary edema , 1977, Clinical pharmacology and therapeutics.

[18]  N. Shock,et al.  The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure. , 1949, The Journal of clinical investigation.

[19]  Shinichi Kobayashi,et al.  Developmental Changes in Urinary Elimination of Theophylline and Its Metabolites in Pediatric Patients , 1999, Pediatric Research.

[20]  J. Miners,et al.  Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid. , 1983, British journal of clinical pharmacology.